UPDF AI

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.

Anthony L. Cunningham,Himal Lal,28 Authors,T. Heineman

2016 · DOI: 10.1056/NEJMoa1603800
New England Journal of Medicine · 870 Citations

TLDR

HZ/su was found to reduce the risks of herpes zoster and postherpetic neuralgia among adults 70 years of age or older.